Bulk Ingredients for Asia

Premium cannabinoid ingredients for Asian markets. cGMP manufactured, Halal certified, compliant with NDPS Act, MFDS, and Thai FDA.

CBD Ingredients for Asian Markets

Asia is the fastest-growing opportunity for hemp-derived ingredients. Cannvital serves India, South Korea, and Thailand with cGMP manufacturing, Halal certification, and THC ND products tailored to each country’s requirements.

India — Ayurvedic Wellness and Hemp Innovation

NDPS Act Framework

India’s NDPS Act (1985) permits cannabis leaves and seeds (including derivatives) while prohibiting flowers and resin. Hemp = cannabis with THC below 0.3%. Licensed cultivation in Uttarakhand, Himachal Pradesh, Uttar Pradesh, and Madhya Pradesh.

FSSAI Food Regulations

FSSAI recognizes hemp seed products as food. THC limits: 5 mg/kg in food, 0.2 mg/kg in beverages. CBD must not exceed 75 mg/kg in food products. CBD is not permitted as a food additive — only trace amounts naturally occurring in hemp seed products. No CBD health claims allowed.

AYUSH Ministry

AYUSH regulates Ayurvedic cannabis formulations. As of 2025, clinical validation is mandatory for patented cannabis formulations. Full spectrum CBD sold as Ayurvedic products must meet AYUSH standards.

Why Cannvital for India

Halal + Kosher Certified — Essential for India’s diverse religious markets
Ayurvedic Integration — Pure isolates for traditional formulations
Schedule M GMP Alignment — cGMP exceeds India’s pharmaceutical requirements
Competitive Pricing — Volume structures for India’s market
FSSAI Documentation — COAs aligned with FSSAI requirements

South Korea — K-Beauty and Medical CBD

Regulatory Framework

South Korea legalized medical CBD in 2018 (first East Asian country). MFDS oversees approvals with only four approved medicines (Epidiolex, Sativex, Marinol, Cesamet). In 2025, the Supreme Court upheld a ban on CBD in cosmetics, ruling CBD remains a controlled substance regardless of hemp plant origin. The market is medical-only through the Korean Orphan Drug Center (KODC).

Why Cannvital for South Korea

ZeroTrace™ Technology — THC ND below 1ppm for MFDS compliance
Pharmaceutical Grade — 99%+ pure CBD Isolate meeting MFDS pharmaceutical standards
KGMP Alignment — cGMP + FDA registration aligns with Korean pharmaceutical GMP
MFDS Documentation — COAs formatted for Korean regulatory submission

Thailand — Wellness Tourism and Spa Industry

Regulatory Framework

Thailand decriminalized cannabis in 2022, then re-regulated through 2024-2025. Thai FDA requires CBD products with THC below 0.2%. Thailand’s spa and wellness tourism industry drives demand for premium CBD ingredients.